Name | SFTX-3.3 |
---|
Description | sFTX-3.3 is a Ca2+ channel antagonist with IC50s of approximately 0.24 mM and 0.70 mM against P-type and N-type channels[1][2]. |
---|---|
Related Catalog | |
Target |
P-type calcium channel:0.24 mM (IC50) N-Type Ca2+ Channel:0.70 mM (IC50) |
In Vitro | sFTX-3.3 (100 μM) reduces the duration of the slow component of presynaptic calcium currents by about 50% of the control and also reduces presynaptic sodium current by approximately 20% of the control. sFTX-3.3 (100 μM) reduces whole-cell sodium current recorded from SK.N.SH cells by approximately 15%[3]. |
References |
No Any Chemical & Physical Properties |